Notably, our integrated in silico and in vitro analyses reveal that specific bioactive compounds isolated from CC act by regulating CB1 and CB2 receptors, offering a potential mechanism for their protective effects against DEX-induced muscle atrophy. The gene discussed is CNR1; the disease is muscle atrophy.